Article

Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variant

2022-01-19

Abstract excerpt

<title>Abstract</title> <p>The spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the major antigen stimulating the host's protective immune response. A new SARS-CoV-2 variant, designated Omicron, first identified in South Africa and possess many spike protein mutations. Here, we assessed the efficacy of therapeutic monoclonal antibodies (mAbs) against an Omicron variant in Syrian ha...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e9420668-50e5-59f5-b6a1-ca2744556562
DOI: 10.21203/rs.3.rs-1240227/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variantDOI 10.21203/rs.3.rs-1240227/v1Read

Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic AntibodiesSemantic proximity Read

Omicron-specific mRNA vaccine elicits potent immune responses in mice, hamsters, and nonhuman primatesSemantic proximity Read

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodiesSemantic proximity Read

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 modelSemantic proximity Read

Activity of Tixagevimab/Cilgavimab against the Omicron variant of SARS-CoV-2 in a hamster modelSemantic proximity Read

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K VariantsSemantic proximity Read

<i>In vitro</i> evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolateSemantic proximity Read

Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeysSemantic proximity Read

Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particlesSemantic proximity Read

Pathogenicity of SARS-CoV-2 Omicron in Syrian hamsters and its neutralization with different Variants of ConcernSemantic proximity Read

Efficacy of ChAdOx1 vaccines against SARS-CoV-2 Variants of Concern Beta, Delta and Omicron in the Syrian hamster modelSemantic proximity Read

In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolateSemantic proximity Read